Helix
Alexandre Bolze has a strong background in Human Genetics of Infectious Diseases, with experience in molecular and cellular biology research. At Helix, Alexandre holds the position of Principal Scientist, leading projects related to vaccine-associated myocarditis and COVID-19 human genetics. Alexandre has managed teams and developed important research on mitochondrial DNA variants and pharmacogenetics of mRNA vaccines. Prior to their current role, Bolze worked as a Postdoctoral Researcher at UCSF and Rockefeller University, contributing to projects in protein translation and human genetics of infectious diseases. Overall, Bolze is a highly accomplished scientist with a wealth of experience in genomic medicine research and population-scale studies.
Helix
9 followers
Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world’s largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+® assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.